Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer

D. Coradini, P. Boracchi, M. Grazia Daidone, C. Pellizzaro, P. Miodini, M. Ammatuna, G. Tomasic, E. Biganzoli

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The prognostic contribution of intratumour VEGF, the most important factor in tumour-induced angiogenesis, to NPI was evaluated by using flexible modelling in a series of 226 N-primary breast cancer patients in which steroid receptors and cell proliferation were also accounted for. VEGF provided an additional prognostic contribution to NPI mainly within ER-poor tumours.

Original languageEnglish
Pages (from-to)795-797
Number of pages3
JournalBritish Journal of Cancer
Volume85
Issue number6
DOIs
Publication statusPublished - Sep 14 2001

Fingerprint

Vascular Endothelial Growth Factor A
Breast Neoplasms
Steroid Receptors
Neoplasms
Cell Proliferation

Keywords

  • Flexible modelling
  • N-negative primary breast cancer
  • NPI
  • VEGF

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer. / Coradini, D.; Boracchi, P.; Daidone, M. Grazia; Pellizzaro, C.; Miodini, P.; Ammatuna, M.; Tomasic, G.; Biganzoli, E.

In: British Journal of Cancer, Vol. 85, No. 6, 14.09.2001, p. 795-797.

Research output: Contribution to journalArticle

Coradini, D. ; Boracchi, P. ; Daidone, M. Grazia ; Pellizzaro, C. ; Miodini, P. ; Ammatuna, M. ; Tomasic, G. ; Biganzoli, E. / Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer. In: British Journal of Cancer. 2001 ; Vol. 85, No. 6. pp. 795-797.
@article{47fca54ac26f45eba4fa1f4a8160456b,
title = "Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer",
abstract = "The prognostic contribution of intratumour VEGF, the most important factor in tumour-induced angiogenesis, to NPI was evaluated by using flexible modelling in a series of 226 N-primary breast cancer patients in which steroid receptors and cell proliferation were also accounted for. VEGF provided an additional prognostic contribution to NPI mainly within ER-poor tumours.",
keywords = "Flexible modelling, N-negative primary breast cancer, NPI, VEGF",
author = "D. Coradini and P. Boracchi and Daidone, {M. Grazia} and C. Pellizzaro and P. Miodini and M. Ammatuna and G. Tomasic and E. Biganzoli",
year = "2001",
month = "9",
day = "14",
doi = "10.1054/bjoc.2001.2019",
language = "English",
volume = "85",
pages = "795--797",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer

AU - Coradini, D.

AU - Boracchi, P.

AU - Daidone, M. Grazia

AU - Pellizzaro, C.

AU - Miodini, P.

AU - Ammatuna, M.

AU - Tomasic, G.

AU - Biganzoli, E.

PY - 2001/9/14

Y1 - 2001/9/14

N2 - The prognostic contribution of intratumour VEGF, the most important factor in tumour-induced angiogenesis, to NPI was evaluated by using flexible modelling in a series of 226 N-primary breast cancer patients in which steroid receptors and cell proliferation were also accounted for. VEGF provided an additional prognostic contribution to NPI mainly within ER-poor tumours.

AB - The prognostic contribution of intratumour VEGF, the most important factor in tumour-induced angiogenesis, to NPI was evaluated by using flexible modelling in a series of 226 N-primary breast cancer patients in which steroid receptors and cell proliferation were also accounted for. VEGF provided an additional prognostic contribution to NPI mainly within ER-poor tumours.

KW - Flexible modelling

KW - N-negative primary breast cancer

KW - NPI

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=0035860130&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035860130&partnerID=8YFLogxK

U2 - 10.1054/bjoc.2001.2019

DO - 10.1054/bjoc.2001.2019

M3 - Article

VL - 85

SP - 795

EP - 797

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 6

ER -